Peripheral Inflammatory Mediators in Parkinson’s Disease – A Potential Biomarker
Objective: i.To determine if post-translationally modified phosphorylated α-synuclein levels are altered in the peripheral blood of Parkinson’s disease (PD) patients compared to control subjects. ii.To…Prevalence and associations for depression in patients with Parkinson’s disease: A Sri Lankan experience
Objective: Estimate the prevalence of depression among patients with PD presenting to a tertiary neurology clinic in the premier healthcare institution in Sri Lanka Identify…Propranolol Induced Visual Hallucinations: A Case Report Charles Bonnets Syndrome in Parkinson Disease
Objective: Charles Bonnets has defined the visual hallucinations (VH) associated with macular degeneration; the syndrome (CBS) is to be remembered by his name. M Background:…Functional Balance and Neuromuscular Strength Difficulties Like Fracture Predictors in a Parkinsonian Population
Objective: To evaluate the strength and function of the hip flexor muscles and knee extensors of elderly patients with Parkinson's disease (PD) to know possible…Validity And Reliability Of Nineteen-Item Wearing-Off Questionnaire In Turkish Patients
Objective: To conduct the validity and reliability study of the Turkish version of nineteen-item wearing-off (WO19)questionnaire. Background: Wearing-off(WO)is probably the most frequent motor complication of…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.